1. Baba M, Castillo A, Koriyama C, Yanagi M, Matsumoto H, Natsugoe S, Shuyama KY, Khan N, Higashi M, Itoh T, Eizuru Y, Aikou T, Akiba S (2010) Human papillomavirus is frequently detected in gefitinib-responsive lung adenocarcinomas. Oncol Rep 23 (4): 1085–1092
2. Backes DM, Kurman RJ, Pimenta JM, Smith JS (2009) Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20: 449–457
3. Berumen J, Unger ER, Casas L, Figueroa P (1995) Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 26: 676–681
4. Cubilla AL, Dillner J, Schellhammer PF, Horenblas S (2004) Tumours of the penis: malignant epithelial tumours. In Eble JN, Sauter G, Epstein JI, Sesterhenn I, (eds) Chap 5. World Health Organization Classification of Tumours Pathology & Genetics of Tumours of the Urinary System and Male Genital Organs pp 281–290. IARC: Lyon
5. Cullen AP, Reid R, Campion M, Lörincz AT (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65: 606–612